z-logo
Premium
Determination of the lipophilic antipsychotic drug ziprasidone in rat plasma and brain tissue using liquid chromatography–tandem mass spectrometry
Author(s) -
Zhang Guodong,
Terry Alvin V.,
Bartlett Michael G.
Publication year - 2008
Publication title -
biomedical chromatography
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.4
H-Index - 65
eISSN - 1099-0801
pISSN - 0269-3879
DOI - 10.1002/bmc.999
Subject(s) - chemistry , chromatography , ziprasidone , formic acid , selected reaction monitoring , matrix (chemical analysis) , tandem mass spectrometry , mass spectrometry , liquid chromatography–mass spectrometry , elution , bioanalysis , electrospray ionization , antipsychotic , schizophrenia (object oriented programming) , computer science , programming language
A simple, sensitive and robust liquid chromatography/electrospray ionization tandem mass spectrometry (LCESI‐MS/MS) method with low matrix effects was developed and validated for the quantification of the lipophilic antipsychotic ziprasidone from rat plasma and brain tissue. Ziprasidone was extracted from rat plasma and brain homogenate using a single‐step liquid–liquid extraction. Ziprasidone was separated on an Agilent Eclipse XDB C 8 column (150 × 2.1 mm i.d., 5 µm) column using a mobile phase of acetonitrile–0.02% ammonia in water (pH 7.20 adjusted with formic acid) using gradient elution. Ziprasidone was detected in the positive ion mode using multiple reaction monitoring. The method was validated and the specificity, linearity, lower limit of quantitation (LLOQ), precision, accuracy, recovery, matrix effects and stability were determined. The LLOQ was 0.2 ng/mL for plasma and 0.833 ng/g for brain tissue. The method was linear over the concentration range from 0.2 to 200.0 ng/mL for plasma and 0.833–833.3 ng/g for brain tissue. The correlation coefficient ( R 2 ) values were more than 0.996 for both plasma and brain homogenate. The precision and accuracy intra‐day and inter‐day were better than 8.13%. The relative and absolute recovery was above 81.0% and matrix effects were lower than 5.2%. This validated method has been successfully used to quantify the rat plasma and brain tissue concentration of ziprasidone after chronic treatment. Copyright © 2008 John Wiley & Sons, Ltd.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here